A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
Clinical trial NCT01170078 · COMPLETED
Trial details
- NCT number
- NCT01170078
- Sponsor
- Hospira, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-01-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.